|
Volumn 21, Issue 4 B, 2001, Pages 2925-2932
|
Immunohistochemical expression of topoisomerase IIα (Topo IIα) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas
a a a a a a |
Author keywords
Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial carcinoma; Etoposide; MRP; MTT assay; Ovarian carcinoma; Topoisomerase II
|
Indexed keywords
4 HYDROPEROXYCYCLOPHOSPHAMIDE;
CISPLATIN;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DNA TOPOISOMERASE 2ALPHA INHIBITOR;
DOXORUBICIN;
ETOPOSIDE;
MULTIDRUG RESISTANCE PROTEIN;
TETRAZOLIUM;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CELL DIFFERENTIATION;
CHEMOSENSITIVITY;
CLEAR CELL CARCINOMA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENDOMETRIUM CARCINOMA;
FEMALE;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
OVARY CARCINOMA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TUMOR GROWTH;
ADENOCARCINOMA, CLEAR CELL;
ADULT;
AGED;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, ENDOMETRIOID;
CELL DIFFERENTIATION;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYSTADENOCARCINOMA, SEROUS;
CYTOPLASM;
DNA TOPOISOMERASES, TYPE II, EUKARYOTIC;
DNA-BINDING PROTEINS;
DOXORUBICIN;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
ENDOMETRIAL NEOPLASMS;
ETOPOSIDE;
FEMALE;
HUMANS;
MEMBRANE PROTEINS;
MIDDLE AGED;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;
NEOPLASM PROTEINS;
OVARIAN NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
EID: 0035160615
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (26)
|
References (26)
|